|Bid||0.0000 x 4000|
|Ask||0.0000 x 1800|
|Day's Range||0.8500 - 0.8900|
|52 Week Range||0.5500 - 1.5500|
|Beta (3Y Monthly)||1.63|
|PE Ratio (TTM)||4.10|
|Earnings Date||May 13, 2019 - May 17, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.00|
ORLANDO, FL / ACCESSWIRE / March 13, 2019 / In the world of smaller equities, revenue, especially for emerging biotech or tech companies, can be fleeting, rare even. As such, Spherix Incorporated (SPEX) posting a one-time gain of $7.5 million in its 10-K should turn a few heads. It is notable that the $7.5 million one-time gain comes from an investment the Company and Spherex CEO Anthony Hayes made two years ago, putting $670k into a then private biotech called Hoth Therapeutics where Hayes saw potential and promise.
NEW YORK , March 12, 2019 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX)- a technology development company committed to the fostering of innovative ideas, announced today that it has filed its Annual ...
NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced the funding of a study for KPC34, for pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDA). PDA is considered the deadliest of major cancers and patients are in desperate need of improved therapies. PDA is caused by chronic inflammatory stress associated with the increasingly common afflictions of obesity, type 2 diabetes, and pancreatitis, exacerbated by smoking and drinking. KPC34 is a candidate therapeutic because it is activated preferentially inside tumor cells to release an inhibitor of DNA replication and a separate tumor promotion inhibitor. Annually, more than 350,000 new cases of pancreatic cancer are diagnosed across the world. According to the American Society of Clinical Oncology, a six-month course of gemcitabine, the chemotherapy drug typically used to treat advanced pancreatic cancer, costs about $23,500.
NEW YORK, NY / ACCESSWIRE / November 27, 2018 / Twilio shares were on the rise on an “outperform” rating reiterated from an Oppenheimer analyst last week while Spherix Incorporated shares popped on news ...
From renting out an unused road bike, to running a fleet of hundreds of electric scooters, Mellow provides a flexible entry for anyone interested in the growing shared vehicles space. Additional information about the investment will be available in the Form 8-K, filed by Spherix with the Securities and Exchange Commission.
NEW YORK, Oct. 29, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced that it has added Dr. Rana Quraishi to the Company's Advisory Board to assist the Company in evaluating potential opportunities in the biopharmaceutical area. Dr. Rana Quraishi is the Director of New Ventures, at UM Ventures University of Maryland, Baltimore. UM Ventures is a joint initiative bringing the University of Maryland, Baltimore and University of Maryland, College Park together to commercialize discoveries and create economic impact by engaging partners in industry and social ventures. Dr. Quraishi has a Ph.D. in Molecular Biology and Biochemistry from Columbia University where she was also an undergraduate and an M.S. from Harvard University.
Las Vegas, Nevada--(Newsfile Corp. - October 25, 2018) - Early stage biotechnology and pharmaceutical companies often present a quandary for investors. The technology is generally difficult to understand and investors just can't fully picture the potential.Except when that picture is an absolutely stunning, must-see video from Wake Forest University of a mouse paralyzed by Acute Lymphoblastic Leukemia restored to mobility in two days by a drug now headed to the patent portfolio of ...
Anthony Hayes, CEO of Spherix, stated, "This remarkable video demonstrates the tremendous potential for this drug to treat ALL. The video was part of a written submission on KPC34 to PLOS OneTM a peer reviewed medical journal.
NEW YORK, Oct. 11, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced that it has entered into a merger agreement with CBM BioPharma, Inc. ("CBM") that will transform Spherix into an innovative pharmaceutical company with pioneering drugs and treatments focused on the multibillion dollar oncology therapeutics market. CBM is a privately held pharmaceutical company with exclusive drug development rights from world-renowned partners including Wake Forest Innovations and the University of Texas at Austin. CBM has a team of leading drug development scientists who will be joining Spherix as advisors to advance the technology.
NEW YORK, Aug. 15, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced it has terminated its merger agreement with DatChat. After strategic meetings with DatChat, both organziations believe there is a more effective strategy that will have the best opportunity for long-term growth. The Spherix Board of Directors determined that a strategic equity investment in DatChat will provide a better strategy for shareholders and allow Spherix to benefit from DatChat's platform and projected growth.
Stock Research Monitor: ONE, SPEX, and TISI LONDON, UK / ACCESSWIRE / June 25, 2018 / If you want a free Stock Review on MCO sign up now at www.wallstequities.com/registration . WallStEquities.com has ...
For Spherix Incorporated’s (NASDAQ:SPEX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. SPEX is exposed toRead More...
In this article, I’m going to take a look at Spherix Incorporated’s (NASDAQ:SPEX) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors.Read More...
Spherix and DatChat have been working together to enhance the user experience. The result is Advanced Screenshot Protection that prevents the recipients of your messages and images from being able to take screenshots. If a recipient tries to take a screenshot of a message or image sent from a DatChat user, the recipient will now only capture a blank screen and the sender will be notified that a screenshot was attempted. Additionally, the advanced screenshot prevention protects against other forms of screen capture, including iOS screen recording, AirPlay screen mirroring and QuickTime screen recording.
While small-cap stocks, such as Spherix Incorporated (NASDAQ:SPEX) with its market cap of US$9.13M, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...
Hayes to Discuss the Company's Recent Transformational Acquisition of DatChat NEW YORK , May 8, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX), a technology company committed to advancing innovation ...
- Company to issue 11.5m fewer shares than initially contemplated - Effective Purchase Price Reduction of $15m - Renowned Cyber-Security Veteran Gregg Blattner to join the Board of Directors NEW YORK , ...
Company Details New Opportunities Following DatChat Acquisition NEW YORK , April 11, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) a technology company committed to advancing innovation by participation ...
One of the driving forces of our Company is our pursuit of business strategies and investments that stand to benefit from both the rapid pace of technological change and ever changing complexities of consumer behavior. Spherix's proposed merger with DatChat provides a working solution to the growing privacy problem.
NEW YORK, March 27, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) announced today that the Company has closed an investment in TheBit Daily LLC ("TheBit"), a development stage media and education platform focused on the blockchain and cryptocurrency space. The site provides strategic and intelligently condensed insight to this exciting technology. For more information, please visit: www.thebitdaily.com. TheBit Daily aims to lower the barrier of entry into the blockchain and cryptocurrency technology fields. TheBit informs readers, who range from beginners to experts, through its easy to understand "Guides" on the main concepts behind blockchain and cryptocurrencies. TheBit offers a free custom-curated newsletter that apprises users on the latest updates and events impacting the blockchain and cryptocurrencies sectors.
Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess Spherix Incorporated’s (NASDAQ:SPEX) track record on a highRead More...